$PODD
Análise IAGerado em May 11, 2026
AI Score
Hold$PODD
Insulet Corporation
$PODDNASDAQHealthcareLarge-Cap
Insulet develops the Omnipod insulin management system, a tubeless insulin pump for diabetes management.
Market Cap
$18.0B
Revenue (TTM)
$2.2B
+18.0%
Net Income (TTM)
$0.2B
+25.0%
EPS (TTM)
$2.80
P/E Ratio
72.0
Dividend Yield
0.0%
52-Week Range
$155-$275
Beta
0.82
Dimension Scores
Fundamental
66Technical
68Sentiment
76Risk / Reward
64Momentum
78Financial Health
Profitability
71moderate
Growth
81strong
Liquidity
72strong
Solvency
68strong
Efficiency
64strong
Valuation, technical analysis, investment thesis, risk assessment and more for $PODD
Free · No credit card required
Aviso: Análise gerada por IA apenas para fins educacionais. Não constitui aconselhamento financeiro. Sempre consulte um consultor financeiro qualificado.